Skip to content Menu
Science Chronicle

Science Chronicle

A Science and Technology Blog

Sidebar
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad

Category: Moderna

Posted on December 5, 2020

COVID-19: Challenges in achieving herd immunity through vaccination

But the government’s idea of vaccinating a “critical mass of people” for the purpose of breaking the virus transmission chain is riddled with problems. Unlike the mRNA vaccines from Pfizer…

Continue Reading
Posted on December 1, 2020

Moderna’s mRNA vaccine has 94.1% efficacy in final analysis, has applied for EUA

According to the release, the Phase-3 trial has exceeded two months of median follow-up post vaccination as required by the U.S. FDA for the purpose of Emergency Use Authorization (EUA). While the…

Continue Reading
Posted on November 22, 2020

Ethics of denying COVID-19 vaccine to placebo group participants once EUA is granted

Offering the vaccine right away to those in the placebo group will first require unblinding the study. Unblinding the study and offering the vaccine to the placebo group will make it almost impossible to gather further information on vaccine efficacy, thus making full licensure challenging.

Continue Reading
Posted on November 19, 2020November 19, 2020

Oxford vaccine found safe and immunogenic even in older adults

The results were published online in The Lancet on November 19. The results are based on the study of 560 participants enrolled between May 30 and August 8. Of the…

Continue Reading
Posted on November 19, 2020November 19, 2020

More mRNA COVID-19 vaccines show stability at higher temperatures

The interim results of Moderna’s mRNA vaccine show that the vaccine has 94.5% efficacy in preventing COVID-19. The interim analysis, which was based on 95 cases, found that 90 participants…

Continue Reading
Posted on November 8, 2020December 4, 2020

It makes sense to bring people to the vaccine instead of taking COVID-19 vaccine to people in some settings: Gagandeep Kang

Government has prioritised certain groups to receive the vaccine first. Which vulnerable groups do you think should receive the vaccine on priority?  Frontline healthcare workers at every level should receive vaccines when…

Continue Reading
Posted on October 9, 2020October 10, 2020

FDA shows spine, rules out COVID-19 vaccines before Presidential election

With at least two months follow-up data likely to be available earliest only by November or December, the guidance essentially shuts the door on vaccine manufacturers making their vaccines available…

Continue Reading
Posted on July 22, 2020July 22, 2020

Results of coronavirus vaccine trials call for cautious optimism

Never before have candidate vaccines been developed from scratch, tested on animals and completed early stages of human clinical trials all under six months. This is an acid test for…

Continue Reading

Posts navigation

Previous Page Page 1 Page 2 Page 3 Next Page
Follow Science Chronicle on WordPress.com

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 10,656 other followers

Archives

Social

  • View Prasad.Ravindranath’s profile on Facebook
  • View @RPrasad12’s profile on Twitter
  • View Prasad.Ravindranath@gmail.com’s profile on Google+

Recent Posts

  • Vaccinate all above 45 years to avoid vaccine inequities February 26, 2021
  • People above 45 years with comorbidities will need doctor certificate, says task force member February 25, 2021
  • Are the variants causing a spike in cases in India? February 24, 2021
  • Covaxin has only 10% takers nationally; less than 1% uptake in 12 States, Union Territories February 22, 2021
  • Daily vaccination rate will soon increase exponentially, says task force member February 21, 2021

Most Read Posts

  • People above 45 years with comorbidities will need doctor certificate, says task force member
  • Are the variants causing a spike in cases in India?
  • UGC’s revised white list has 71 active predatory journals
  • Vaccinate all above 45 years to avoid vaccine inequities
  • 'Serum’s pneumococcal vaccine will be available by June 2020'
  • UGC removes 4,305 journals from White list, including the Lancet Public Health
  • ICMR-NICED scientist has 16 papers with duplicated, manipulated images
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad
Create a website or blog at WordPress.com
Top
Follow Science Chronicle on WordPress.com

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 10,656 other followers

Archives

Cancel

 
Loading Comments...
Comment
    ×